{"DataElement":{"publicId":"6155897","version":"1","preferredName":"Treatment Cohort Study 10030 Code","preferredDefinition":"The code that represents the information pertaining to protocol 10030 in which subsets of a defined population are identified.","longName":"TX_COH_SDY_10030_CD","context":"Theradex","contextVersion":"1","DataElementConcept":{"publicId":"2497526","version":"1","preferredName":"Treatment Cohort Study","preferredDefinition":"Information pertaining to studies in which subsets of a defined population are identified. These groups may or may not be exposed to factors hypothesized to influence the probability of the occurrence of a particular disease or other outcome. Cohorts are defined populations which, as a whole, are followed in an attempt to determine distinguishing subgroup characteristics.","longName":"TX_COHORT_STDY","context":"DCP","contextVersion":"1","ObjectClass":{"publicId":"2416951","version":"1","preferredName":"Therapy","preferredDefinition":"An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.","longName":"C15368","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Therapy","conceptCode":"C15368","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"02DBEE3F-243E-103A-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-10-12","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-10-12","modifiedBy":"ONEDATA","dateModified":"2005-10-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2497524","version":"1","preferredName":"Cohort Study","preferredDefinition":"Studies in which subsets of a defined population are identified. These groups may or may not be exposed to factors hypothesized to influence the probability of the occurrence of a particular disease or other outcome. Cohorts are defined populations which, as a whole, are followed in an attempt to determine distinguishing subgroup characteristics.","longName":"C15208","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cohort Study","conceptCode":"C15208","definition":"A research study that compares a particular outcome (such as lung cancer) in groups of individuals who are alike in many ways but differ by a certain characteristic (for example, female nurses who smoke compared with those who do not smoke).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"191BBE49-FC9E-4C77-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-07-21","endDate":null,"createdBy":"MAESKEB","dateCreated":"2006-07-21","modifiedBy":"ONEDATA","dateModified":"2006-07-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"191BBE49-FCAF-4C77-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-07-21","endDate":null,"createdBy":"MAESKEB","dateCreated":"2006-07-21","modifiedBy":"SOKKERL","dateModified":"2017-05-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6155896","version":"1","preferredName":"10030 Cohort Code","preferredDefinition":"A group of individuals, identified by a common characteristic._A symbol or combination of symbols which is assigned to the members of a collection.","longName":"10030_COH_CODE","context":"Theradex","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"10","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"TAC-0","valueDescription":"TAC-0: Signed Informed Consent and prior to intervention","ValueMeaning":{"publicId":"5916609","version":"1","preferredName":"TAC-0: Signed Informed Consent and prior to intervention","longName":"5916609","preferredDefinition":"TAC-0: Signed Informed Consent and prior to intervention","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"55A283B9-8C33-4F2E-E053-F662850A9164","latestVersionIndicator":"Yes","beginDate":"2017-07-31","endDate":null,"createdBy":"MAESKEB","dateCreated":"2017-07-31","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6890BB71-7BD0-3EF1-E053-F662850A6090","beginDate":"2018-03-29","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-03-29","modifiedBy":"ONEDATA","dateModified":"2018-03-29","deletedIndicator":"No"},{"value":"DLB1","valueDescription":"DLB1: C1 AMG103 9ug/d CIV d1-7 then 28ug/d d8-28, Nivo 240mg IV/60mn d11 then Q2W, Ipi 1mg/kg IV/90mn d11 then Q6W; C2-5 AMG103 28ug/d CIV d1-28, Nivo 240mg IV/60mn Q2W, Ipi 1mg/kg IV/90mn Q6W;  C6+ Nivo 240mg IV/60mn Q2W, Ipi 1mg/kg IV/90mn Q6W","ValueMeaning":{"publicId":"6155918","version":"1","preferredName":"DLB1: C1 AMG103 9ug/d CIV d1-7 then 28ug/d d8-28, Nivo 240mg IV/60mn d11 then Q2W, Ipi 1mg/kg IV/90mn d11 then Q6W; C2-5 AMG103 28ug/d CIV d1-28, Nivo 240mg IV/60mn Q2W, Ipi 1mg/kg IV/90mn Q6W;  C6+ Nivo 240mg IV/60mn Q2W, Ipi 1mg/kg IV/90mn Q6W","longName":"6155918","preferredDefinition":"DLB1: C1 AMG103 9ug/d CIV d1-7 then 28ug/d d8-28, Nivo 240mg IV/60mn d11 then Q2W, Ipi 1mg/kg IV/90mn d11 then Q6W; C2-5 AMG103 28ug/d CIV d1-28, Nivo 240mg IV/60mn Q2W, Ipi 1mg/kg IV/90mn Q6W;  C6+ Nivo 240mg IV/60mn Q2W, Ipi 1mg/kg IV/90mn Q6W","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6890BB71-7BE3-3EF1-E053-F662850A6090","latestVersionIndicator":"Yes","beginDate":"2018-03-29","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-03-29","modifiedBy":"ONEDATA","dateModified":"2018-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6890BB71-7BFC-3EF1-E053-F662850A6090","beginDate":"2018-03-29","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-03-29","modifiedBy":"ONEDATA","dateModified":"2018-03-29","deletedIndicator":"No"},{"value":"DLB-1","valueDescription":"DLB-1: C1 AMG103 9ug/d CIV d1-7 then 28ug/d d8-28; Nivo 80mg IV/60mn d11 then Q2W,  Ipi 1mg/kg IV/90mn d11 then Q6W; C2-5 AMG103 28ug/d CIV d1-28, Nivo 80mg IV/60mn Q2W, Ipi 1mg/kg IV/90mn  Q6W; C6+ Nivo  80mg IV/60mn Q2W, Ipi 1mg/kg IV/90mn Q6W","ValueMeaning":{"publicId":"6155919","version":"1","preferredName":"DLB-1: C1 AMG103 9ug/d CIV d1-7 then 28ug/d d8-28; Nivo 80mg IV/60mn d11 then Q2W,  Ipi 1mg/kg IV/90mn d11 then Q6W; C2-5 AMG103 28ug/d CIV d1-28, Nivo 80mg IV/60mn Q2W, Ipi 1mg/kg IV/90mn  Q6W; C6+ Nivo  80mg IV/60mn Q2W, Ipi 1mg/kg IV/90mn Q6W","longName":"6155919","preferredDefinition":"DLB-1: C1 AMG103 9ug/d CIV d1-7 then 28ug/d d8-28; Nivo 80mg IV/60mn d11 then Q2W,  Ipi 1mg/kg IV/90mn d11 then Q6W; C2-5 AMG103 28ug/d CIV d1-28, Nivo 80mg IV/60mn Q2W, Ipi 1mg/kg IV/90mn  Q6W; C6+ Nivo  80mg IV/60mn Q2W, Ipi 1mg/kg IV/90mn Q6W","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6890BB71-7C06-3EF1-E053-F662850A6090","latestVersionIndicator":"Yes","beginDate":"2018-03-29","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-03-29","modifiedBy":"ONEDATA","dateModified":"2018-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6890BB71-7C1F-3EF1-E053-F662850A6090","beginDate":"2018-03-29","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-03-29","modifiedBy":"ONEDATA","dateModified":"2018-03-29","deletedIndicator":"No"},{"value":"DLA1","valueDescription":"DLA1: Cycle 1 AMG 103 9ug/day CIV d1-7 then 28ug/day d8-28,  Nivo 240mg IV/60 min d11 then Q2W; Cycles 2-5 AMG 103 28ug/day CIV d1-28,  Nivo 240mg IV/60 min Q2W; Cycles 6+ Nivo 240mg IV/60 min Q2W","ValueMeaning":{"publicId":"6155920","version":"1","preferredName":"DLA1: Cycle 1 AMG 103 9ug/day CIV d1-7 then 28ug/day d8-28,  Nivo 240mg IV/60 min d11 then Q2W; Cycles 2-5 AMG 103 28ug/day CIV d1-28,  Nivo 240mg IV/60 min Q2W; Cycles 6+ Nivo 240mg IV/60 min Q2W","longName":"6155920","preferredDefinition":"DLA1: Cycle 1 AMG 103 9ug/day CIV d1-7 then 28ug/day d8-28,  Nivo 240mg IV/60 min d11 then Q2W; Cycles 2-5 AMG 103 28ug/day CIV d1-28,  Nivo 240mg IV/60 min Q2W; Cycles 6+ Nivo 240mg IV/60 min Q2W","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6890BB71-7C29-3EF1-E053-F662850A6090","latestVersionIndicator":"Yes","beginDate":"2018-03-29","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-03-29","modifiedBy":"ONEDATA","dateModified":"2018-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6890BB71-7C42-3EF1-E053-F662850A6090","beginDate":"2018-03-29","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-03-29","modifiedBy":"ONEDATA","dateModified":"2018-03-29","deletedIndicator":"No"},{"value":"DLA-1","valueDescription":"DLA-1: Cycle 1 AMG 103 9ug/day CIV d1-7 then 28ug/day d8-28, Nivo 80mg IV/60 min d11 then Q2W;  Cycles 2-5 AMG 103 28ug/day CIV d1-28, Nivo 80mg IV/60 min Q2W;  Cycles 6+ Nivo 80mg IV/60  min Q2W","ValueMeaning":{"publicId":"6155921","version":"1","preferredName":"DLA-1: Cycle 1 AMG 103 9ug/day CIV d1-7 then 28ug/day d8-28, Nivo 80mg IV/60 min d11 then Q2W;  Cycles 2-5 AMG 103 28ug/day CIV d1-28, Nivo 80mg IV/60 min Q2W;  Cycles 6+ Nivo 80mg IV/60  min Q2W","longName":"6155921","preferredDefinition":"DLA-1: Cycle 1 AMG 103 9ug/day CIV d1-7 then 28ug/day d8-28, Nivo 80mg IV/60 min d11 then Q2W;  Cycles 2-5 AMG 103 28ug/day CIV d1-28, Nivo 80mg IV/60 min Q2W;  Cycles 6+ Nivo 80mg IV/60  min Q2W","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6890BB71-7C4C-3EF1-E053-F662850A6090","latestVersionIndicator":"Yes","beginDate":"2018-03-29","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-03-29","modifiedBy":"ONEDATA","dateModified":"2018-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6890BB71-7C65-3EF1-E053-F662850A6090","beginDate":"2018-03-29","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-03-29","modifiedBy":"ONEDATA","dateModified":"2018-03-29","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"4386398","version":"1","preferredName":"Cohort Code","preferredDefinition":"A group of individuals, identified by a common characteristic.:A system of numbered categories for representation of data.","longName":"C61512:C25162","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cohort","conceptCode":"C61512","definition":"A group of individuals, identified by a common characteristic.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Code","conceptCode":"C25162","definition":"A symbol or combination of symbols which is assigned to the members of a collection.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FE558C16-1C27-C6A8-E040-BB89AD430BEE","latestVersionIndicator":"Yes","beginDate":"2014-07-16","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-07-16","modifiedBy":"ONEDATA","dateModified":"2014-07-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6890BB71-7BB9-3EF1-E053-F662850A6090","latestVersionIndicator":"Yes","beginDate":"2018-03-29","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-03-29","modifiedBy":"TAYLORT","dateModified":"2018-11-08","changeDescription":"11/8/18 TT released/PClark.; Curated to support EC10030_ghd_03.29.17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"3876594","version":"1","longName":"Theradex","context":"Theradex","ClassificationSchemeItems":[{"publicId":"3876603","version":"1","longName":"Theradex - CTMS 3.14","context":"Theradex"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Treatment cohort","type":"Preferred Question Text","description":"Treatment cohort","url":null,"context":"Theradex"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6890CFA9-6CF2-1B07-E053-F662850A7065","latestVersionIndicator":"Yes","beginDate":"2018-03-29","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-03-29","modifiedBy":"SOKKERL","dateModified":"2019-02-07","changeDescription":"11/9/18 TT released/PClark. Curated to support protocol 10030_ghd_03.296.18","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}